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Sorption of study compounds to test soil.
64
The sorption behaviour of the study APIs in the test soil was assessed using a batch (Table 2 ).
S9
Toxicity of study compounds to Eisenia fetida. tetracyclines.
S11
Preparation of soil, pore water and earthworm samples for analysis.
115
To extract pore water, soil (25 ± 2 g) was placed in a disposable syringe with a layer of 3 cm 
S13

Potential metabolism in earthworms 157
Methods:
158
To ascertain whether the radioactivity we were measuring in our earthworm samples was that 159 of the parent compound or metabolite/transformation products, additional studies were 160 performed using unlabelled compounds. Studies were performed at 20 times the soil 161 concentration used in the radiolabelling studies to ensure that compounds were detectable in 162 the worm matrix.
163
E. fetida were exposed to unlabelled carbamazepine, diclofenac and fluoxetine for 21 days
164
(six replicates per compound) under similar conditions to the original studies, after which 
198
For the calibration range of 0 -1500 ng/mL, 0 -800 ng/mL and 0 -1375 ng/mL the R 2 of 199 calibration fits are 0.92, 0.98, 0.99 for carbamazepine, diclofenac, fluoxetine respectively.
200
The mean accuracy for the QC's ranged between 88.6 -108.5%, 95.8 -97.6% and 82.1 - was estimated (see Table SI 3).
219
Both carbamazepine and fluoxetine were detected in the worm tissue at concentrations 220 slightly greater than expected. Diclofenac was not detected. Diclofenac worm extracts were 221 subsequently analysed using LC-FTMS to look for known diclofenac metabolites and 222 transformation products using a Dionex Ultimate 3000 HPLC and solariX 9.4 T (Bruker) FT-
223
ICR mass spectrometer (known metabolites are provided in Table SI 5 ).
